is a resource by Feldesman Tucker Leifer Fidell LLP

Questions? Contact Us Today!
1-800-266-1938 | Email

HomeProducts › 340B Drug Discount Program Risk Assessment

340B Drug Discount Program Risk Assessment

Monitor the progress of your compliance efforts by assessing your health center’s compliance with the requirements for the 340B Drug Discount Program (HRSA policies).


Product Details

The 340B Drug Discount Program (HRSA policies) risk assessment includes the following topics:

  • Site registration 
  • Patient definition 
  • Double discount avoidance 
  • Drug diversion/arrangements with providers
  • Contract pharmacy arrangements
  • Medicaid exclusion file accuracy
  • Responsible official/contact person

After your health center uploads the requested documents into our secure website, FTLF will prepare a final report that addresses the following items:

  1. Assessment of selected compliance domains with a standard grading scale to indicate current level of compliance risk;
  2. Explanation in detail of particular elements within each compliance domain that the health center should work towards;
  3. Prioritized recommendations for individual health center compliance improvements; and,
  4. Prioritized recommendations for compliance training and technical assistance.